Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taipei Exchange - Delayed Quote TWD

Medical Imaging Corporation (6637.TWO)

Compare
75.50
-8.30
(-9.90%)
At close: 11:08:16 AM GMT+8
Loading Chart for 6637.TWO
  • Previous Close 83.80
  • Open 75.50
  • Bid --
  • Ask 75.50 x --
  • Day's Range 75.50 - 75.50
  • 52 Week Range 75.50 - 152.00
  • Volume 26,882
  • Avg. Volume 27,590
  • Market Cap (intraday) 1.835B
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) 10.56
  • EPS (TTM) 7.15
  • Earnings Date --
  • Forward Dividend & Yield 2.65 (3.16%)
  • Ex-Dividend Date Sep 2, 2024
  • 1y Target Est --

Medical Imaging Corporation provides imaging medical leasing and management services in China. The company's products include Ultrasound, bone density detectors, emergency rooms and intensive isolation wards, and intelligent radiation protection lead plates. It also distributes medical equipment and drugs. The company was founded in 1978 and is based in Taipei, Taiwan.

www.mic-tw.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6637.TWO

View More

Performance Overview: 6637.TWO

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6637.TWO
20.02%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
16.51%

1-Year Return

6637.TWO
11.27%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
5.43%

3-Year Return

6637.TWO
91.76%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
11.96%

5-Year Return

6637.TWO
130.49%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
92.39%

Compare To: 6637.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6637.TWO

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    2.04B

  • Enterprise Value

    1.64B

  • Trailing P/E

    11.72

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.33

  • Price/Book (mrq)

    2.28

  • Enterprise Value/Revenue

    1.98

  • Enterprise Value/EBITDA

    6.24

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.91%

  • Return on Assets (ttm)

    12.17%

  • Return on Equity (ttm)

    22.66%

  • Revenue (ttm)

    829.03M

  • Net Income Avi to Common (ttm)

    165.02M

  • Diluted EPS (ttm)

    7.15

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    487.29M

  • Total Debt/Equity (mrq)

    10.54%

  • Levered Free Cash Flow (ttm)

    130.71M

Research Analysis: 6637.TWO

View More

Company Insights: 6637.TWO

Research Reports: 6637.TWO

View More

People Also Watch